Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Diabetes Drug Therapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Diabetes Drug Therapymarket, defines the market attractiveness level of Diabetes Drug Therapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Diabetes Drug Therapy industry, describes the types of Diabetes Drug Therapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Diabetes Drug Therapy market and the development prospects and opportunities of Diabetes Drug Therapy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Diabetes Drug Therapy market in Chapter 13.
By Player:
GlaxoSmithKline
Sanofi
AstraZeneca
Novartis International AG
Mannkind Corporation
Eli Lilly and Company
Novo Nordisk
Medtronic
Abbott Laboratories
Bristol Myers Squibb
By Type:
Glucagon-like peptide-1 (GLP-1) agonist
Dipeptidyl-peptidase-4 (DPP-4) inhibitors
Sodium glucose co-transporter 2 (SGLT2) inhibitors
Insulin
Others
By End-User:
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Impaired Glucose Tolerance and Impaired Fasting Glycaemia
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Diabetes Drug Therapy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Diabetes Drug Therapy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Diabetes Drug Therapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Diabetes Drug Therapy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Diabetes Drug Therapy Market Analysis and Outlook to 2022
-
7.1 Global Diabetes Drug Therapy Consumption (2017-2022)
-
7.2 United States Diabetes Drug Therapy Consumption (2017-2022)
-
7.3 Europe Diabetes Drug Therapy Consumption (2017-2022)
-
7.4 China Diabetes Drug Therapy Consumption (2017-2022)
-
7.5 Japan Diabetes Drug Therapy Consumption (2017-2022)
-
7.6 India Diabetes Drug Therapy Consumption (2017-2022)
-
7.7 South Korea Diabetes Drug Therapy Consumption (2017-2022)
8 Region and Country-wise Diabetes Drug Therapy Market Analysis and Outlook to 2028
-
8.1 Global Diabetes Drug Therapy Consumption Forecast (2022-2028)
-
8.2 United States Diabetes Drug Therapy Consumption Forecast (2022-2028)
-
8.3 Europe Diabetes Drug Therapy Consumption Forecast (2022-2028)
-
8.4 China Diabetes Drug Therapy Consumption Forecast (2022-2028)
-
8.5 Japan Diabetes Drug Therapy Consumption Forecast (2022-2028)
-
8.6 India Diabetes Drug Therapy Consumption Forecast (2022-2028)
-
8.7 South Korea Diabetes Drug Therapy Consumption Forecast (2022-2028)
9 Global Diabetes Drug Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global Diabetes Drug Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Glucagon-like peptide-1 (GLP-1) agonist Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Dipeptidyl-peptidase-4 (DPP-4) inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Sodium glucose co-transporter 2 (SGLT2) inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Insulin Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Diabetes Drug Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Type 1 Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Gestational Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Impaired Glucose Tolerance and Impaired Fasting Glycaemia Consumption and Growth Rate (2017-2022)
10 Global Diabetes Drug Therapy Market Outlook by Types and Applications to 2028
-
10.1 Global Diabetes Drug Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Glucagon-like peptide-1 (GLP-1) agonist Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Dipeptidyl-peptidase-4 (DPP-4) inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Sodium glucose co-transporter 2 (SGLT2) inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Insulin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Diabetes Drug Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Type 1 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Gestational Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Impaired Glucose Tolerance and Impaired Fasting Glycaemia Consumption Forecast and Growth Rate (2022-2028)
11 Global Diabetes Drug Therapy Import and Export Analysis (Top 5 Countries)
-
11.1 Global Diabetes Drug Therapy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Diabetes Drug Therapy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Diabetes Drug Therapy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Diabetes Drug Therapy Market Competitive Analysis
-
14.1 GlaxoSmithKline
-
14.1.1 GlaxoSmithKline Company Details
-
14.1.2 GlaxoSmithKline Diabetes Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GlaxoSmithKline Diabetes Drug Therapy Product and Service
-
14.2 Sanofi
-
14.2.1 Sanofi Company Details
-
14.2.2 Sanofi Diabetes Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sanofi Diabetes Drug Therapy Product and Service
-
14.3 AstraZeneca
-
14.3.1 AstraZeneca Company Details
-
14.3.2 AstraZeneca Diabetes Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AstraZeneca Diabetes Drug Therapy Product and Service
-
14.4 Novartis International AG
-
14.4.1 Novartis International AG Company Details
-
14.4.2 Novartis International AG Diabetes Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis International AG Diabetes Drug Therapy Product and Service
-
14.5 Mannkind Corporation
-
14.5.1 Mannkind Corporation Company Details
-
14.5.2 Mannkind Corporation Diabetes Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Mannkind Corporation Diabetes Drug Therapy Product and Service
-
14.6 Eli Lilly and Company
-
14.6.1 Eli Lilly and Company Company Details
-
14.6.2 Eli Lilly and Company Diabetes Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Eli Lilly and Company Diabetes Drug Therapy Product and Service
-
14.7 Novo Nordisk
-
14.7.1 Novo Nordisk Company Details
-
14.7.2 Novo Nordisk Diabetes Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novo Nordisk Diabetes Drug Therapy Product and Service
-
14.8 Medtronic
-
14.8.1 Medtronic Company Details
-
14.8.2 Medtronic Diabetes Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Medtronic Diabetes Drug Therapy Product and Service
-
14.9 Abbott Laboratories
-
14.9.1 Abbott Laboratories Company Details
-
14.9.2 Abbott Laboratories Diabetes Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Abbott Laboratories Diabetes Drug Therapy Product and Service
-
14.10 Bristol Myers Squibb
-
14.10.1 Bristol Myers Squibb Company Details
-
14.10.2 Bristol Myers Squibb Diabetes Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Bristol Myers Squibb Diabetes Drug Therapy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Diabetes Drug Therapy
-
Figure Diabetes Drug Therapy Picture
-
Table Global Diabetes Drug Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Diabetes Drug Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Diabetes Drug Therapy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Diabetes Drug Therapy Consumption by Country (2017-2022)
-
Figure United States Diabetes Drug Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe Diabetes Drug Therapy Consumption and Growth Rate (2017-2022)
-
Figure China Diabetes Drug Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Diabetes Drug Therapy Consumption and Growth Rate (2017-2022)
-
Figure India Diabetes Drug Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Diabetes Drug Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Drug Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States Diabetes Drug Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Diabetes Drug Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Diabetes Drug Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Diabetes Drug Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Diabetes Drug Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Diabetes Drug Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glucagon-like peptide-1 (GLP-1) agonist Consumption and Growth Rate (2017-2022)
-
Figure Global Dipeptidyl-peptidase-4 (DPP-4) inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Sodium glucose co-transporter 2 (SGLT2) inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Type 1 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Type 2 Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Gestational Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Impaired Glucose Tolerance and Impaired Fasting Glycaemia Consumption and Growth Rate (2017-2022)
-
Figure Global Glucagon-like peptide-1 (GLP-1) agonist Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dipeptidyl-peptidase-4 (DPP-4) inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sodium glucose co-transporter 2 (SGLT2) inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 1 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gestational Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Impaired Glucose Tolerance and Impaired Fasting Glycaemia Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Diabetes Drug Therapy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Diabetes Drug Therapy Export by Region (Top 5 Countries) (2017-2028)
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Diabetes Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Diabetes Drug Therapy Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Diabetes Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Diabetes Drug Therapy Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Diabetes Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Diabetes Drug Therapy Product and Service
-
Table Novartis International AG (Foundation Year, Company Profile and etc.)
-
Table Novartis International AG Diabetes Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis International AG Diabetes Drug Therapy Product and Service
-
Table Mannkind Corporation (Foundation Year, Company Profile and etc.)
-
Table Mannkind Corporation Diabetes Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mannkind Corporation Diabetes Drug Therapy Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Diabetes Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Diabetes Drug Therapy Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Diabetes Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Diabetes Drug Therapy Product and Service
-
Table Medtronic (Foundation Year, Company Profile and etc.)
-
Table Medtronic Diabetes Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medtronic Diabetes Drug Therapy Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Diabetes Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Diabetes Drug Therapy Product and Service
-
Table Bristol Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol Myers Squibb Diabetes Drug Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol Myers Squibb Diabetes Drug Therapy Product and Service
-
